(Q34513577)

2 August 2017

title

Genetic alterations of the BRI2 gene: familial British and Danish dementias (English)

1 reference

2 August 2017

J Ghiso

1

1 reference

2 August 2017

A Rostagno

2

1 reference

2 August 2017

Y Tomidokoro

3

1 reference

2 August 2017

T Lashley

4

1 reference

2 August 2017

M Bojsen-Møller

5

1 reference

2 August 2017

H Braendgaard

6

1 reference

2 August 2017

G Plant

7

1 reference

2 August 2017

J Holton

8

1 reference

2 August 2017

R Lal

9

1 reference

2 August 2017

T Revesz

10

1 reference

2 August 2017

B Frangione

11

1 reference

2 August 2017

publication date

1 January 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

16

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

71-79

1 reference

Inflammation and Alzheimer's disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Architecture of the Alzheimer's A beta P ion channel pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Amyloid beta peptide induces necrosis rather than apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Ocular changes in heredo-oto-ophthalmo-encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Caspases: cellular demolition experts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Apoptotic and necrotic cell death induced by death domain receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

The role of complement in Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Induction of p53-independent apoptosis by the BH3-only protein ITM2Bs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Systemic amyloid deposits in familial British dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Protofibrils, the unifying toxic molecule of neurodegenerative disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

21 January 2018

Amyloid peptide channels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Neurodegenerative disease: amyloid pores from pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Apoptosis in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Genomic organization and chromosomal localization of the Itm2a gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Amyloid ion channels: a common structural link for protein-misfolding disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

21 January 2018

Chromosome 13 dementias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Evidence for tissue-specific forms of glutaminyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

A stop-codon mutation in the BRI gene associated with familial British dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00563.X

10.1111/J.1750-3639.2006.TB00563.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference